SearchSkip to Search Results
Establishing Translational Research Pipelines for Smart Devices
The development of a translational research path has traditionally been a haphazard approach, filtering technologies so that the ‘best of breed’ may ultimately succeed. The conversion ratio of brilliant ideas to useful devices remains suboptimal, as many ‘fail to progress’. The reality of...
Nanotechnology & Medical Devices: Risk, Regulation and ‘Meta’ Registration
Integrating data services across the life science spectrum illustrates the design and development of novel therapies in terms of Translational Research (TR) paths. The aim is to build an ‘open’ registry from multiple centres by allowing for open archiving of key characteristics of materials used...
The rules of governance are changing. They are necessarily becoming more stringent as interventions offered to treat conditions carry unpredictable side effects, often associated with novel therapeutic vectors. The clinical relevance of this relates to the obligations of those involved in...